Author

Franck Touret

InsermORCID 0000-0002-4734-2249Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

Antoine NougaırèdeiD· 1 shared Boris A. M. PastorinoiD· 1 shared Donna Busler· 1 shared Fanny Reyre· 1 shared Francois Billecard· 1 shared Jean Charles Morand· 1 shared Jean‐Sélim DriouichiD· 1 shared Michaël Jousserand· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Antoine NougaırèdeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Material-specific quarantine durations for SARS-CoV-2 inactivation on musical instruments and music-related materials

Boris A. M. Pastorino, Franck Touret, Milena Creton, Romain Viala, Jean Charles Morand, Fanny Reyre, Michaël Jousserand, Francois Billecard, Rémi N. Charrel

This study determines SARS-CoV-2 inactivation times on musical materials, showing variability based on porosity and composition, with non-porous surfaces clearing virus in 3 days and porous ones requiring up to 7 days.

bioRxiv · Jul 1, 2026 · PreprintMicrobiology

Assessing Human Liver Spheroids as a Model for Antiviral Drug Evaluation Against BSL-3 Haemorrhagic Fever viruses

Sarah Chaput, Jean‐Sélim Driouich, Simon Gruber, Donna Busler, Xavier Nicolas de Lamballerie, Antoine Nougaırède, Franck Touret

This study evaluates a human liver spheroid model for antiviral drug testing against BSL-3 HFVs, finding that some viruses replicate in the model and antiviral compounds show activity with dose variations.

Antiviral Research · May 11, 2025Peer-reviewedMicrobiology